Post-Test on Hepatitis C in Primary Care
Take this brief quiz to see what you’ve learned about the challenges and opportunities of HCV management.
Hepatitis C Drugs Meet Resistance Issues
Resistance-associated variants limit the activity of some drugs, but HIV infection treatment may offer some guidance.
Hepatitis C: What If You Do Not Treat?
Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.
Newer Hepatitis C Drugs Mean Direct Action
The “modern era” of treatment features multiple DAAs that target specific steps within the HCV life cycle.
Medicaid Is Tight on Hepatitis C Drug Coverage
State Medicaid programs and private insurance companies have balked at providing these drugs to their insured customers. But the tide is turning.
Hepatitis C Report: What Tests to Order
Testing is recommended for the persons who are more likely to have the virus but not know it.
Hepatitis C Screening for High Risk Patients
Patients can be identified at earlier stages of disease, before serious liver damage develops, and have improved clinical outcomes.
Gout Rounds: 5 New Developments
Primary care can do more to help reduce gout morbidity, says a new review—plus 4 more studies on gout treatment and prevention.
8 New Rheumatoid Arthritis Findings
RA symptoms invisible but harmful, mortality increases with RA, plus 6 more highlights from recent RA studies of interest to primary care.
10 Opioid Myths and Facts
Do you know the myths from the facts about opioid analgesics? Click through these 10 statements and find out.
Unexplained Hair Loss in a 4-Year-Old Boy
The diagnosis of trichotillomania seemed certain, despite lack of supporting history. It turned out to be about 50% wrong.
By clicking Accept, you agree to become a member of the UBM Medica Community.